# Abingworth Clinical Co-Development Fund 2 LP — Form D

Abingworth Clinical Co-Development Fund 2 LP of LONDON, X0, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2020-12-03. $207.5M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2020-12-03
- Form: D
- Accession: 0001834445-20-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $207.5M
- Investors: 22
- Date of first sale: 2020-11-19
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-382087

## Issuer

- Name: Abingworth Clinical Co-Development Fund 2 LP
- CIK: 0001834445
- Entity type: Limited Partnership
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2020
- Address: 38 JERMYN STREET, LONDON, X0, SW1Y 6DN
- Phone: 44 0 20 7534 1508

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| - Abingworth Clinical Co-Development Fund 2 GP LP | Promoter | EDINBURGH, X0 |
| - Abingworth LLP | Promoter | LONDON, X0 |

## More

- [CIK 1834445 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1834445&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001834445-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.